{
  "actions": [
    {
      "acted_at": "2016-06-23", 
      "action_code": "10000", 
      "references": [], 
      "text": "Introduced in Senate", 
      "type": "action"
    }, 
    {
      "acted_at": "2016-06-23", 
      "action_code": "", 
      "committees": [
        "SSHR"
      ], 
      "references": [], 
      "status": "REFERRED", 
      "text": "Read twice and referred to the Committee on Health, Education, Labor, and Pensions.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "s3094-114", 
  "bill_type": "s", 
  "by_request": false, 
  "committees": [
    {
      "activity": [
        "referral"
      ], 
      "committee": "Senate Health, Education, Labor, and Pensions", 
      "committee_id": "SSHR"
    }
  ], 
  "congress": "114", 
  "cosponsors": [
    {
      "bioguide_id": "M000303", 
      "district": null, 
      "name": "McCain, John", 
      "original_cosponsor": true, 
      "sponsored_at": "2016-06-23", 
      "state": "AZ", 
      "thomas_id": "00754", 
      "title": "Sen", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2016-06-23", 
  "number": "3094", 
  "official_title": "A bill to amend the Public Health Service Act to shorten the exclusivity period for brand name biological products from 12  to 7 years.", 
  "popular_title": null, 
  "related_bills": [
    {
      "bill_id": "hr5573-114", 
      "identified_by": "CRS", 
      "reason": "identical", 
      "type": "bill"
    }
  ], 
  "short_title": "Price Relief, Innovation, and Competition for Essential Drugs Act", 
  "sponsor": {
    "bioguide_id": "B000944", 
    "district": null, 
    "name": "Brown, Sherrod", 
    "state": "OH", 
    "thomas_id": "00136", 
    "title": "Sen", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2016-06-23", 
  "subjects": [
    "Health"
  ], 
  "subjects_top_term": "Health", 
  "summary": {
    "as": "Introduced in Senate", 
    "date": "2016-06-23T04:00:00Z", 
    "text": "Price Relief, Innovation, and Competition for Essential Drugs Act or the PRICED Act\n\nThis bill amends the Public Health Service Act to allow biosimilars to be marketed seven years after the reference brand name biological product is licensed. Currently, brand name biological products are provided a 12-year marketing exclusivity period.\n\nThis shortened marketing exclusivity period applies only to biological products licensed by the Food and Drug Administration after enactment of this bill."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Price Relief, Innovation, and Competition for Essential Drugs Act", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "PRICED Act", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "A bill to amend the Public Health Service Act to shorten the exclusivity period for brand name biological products from 12  to 7 years.", 
      "type": "official"
    }, 
    {
      "as": null, 
      "is_for_portion": false, 
      "title": "PRICED Act", 
      "type": "display"
    }
  ], 
  "updated_at": "2016-08-01T13:31:32Z", 
  "url": "https://www.gpo.gov/fdsys/bulkdata/BILLSTATUS/114/s/BILLSTATUS-114s3094.xml"
}